tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Income Statement

Compare
3,195 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q4 2024), Sarepta Therapeutics's total revenue was $658.41M, an increase of 65.94% from the same quarter last year. In Q4, Sarepta Therapeutics's net income was $159.05M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.90B$ 1.24B$ 933.01M$ 701.89M$ 540.10M
Gross Profit
$ 1.58B$ 1.09B$ 793.02M$ 604.84M$ 476.72M
Operating Expenses
$ 1.36B$ 1.36B$ 1.33B$ 1.05B$ 1.04B
Depreciation and Amortization
$ 37.72M$ 58.89M$ 54.60M$ 49.34M$ 39.74M
EBITDA
$ 316.89M$ -439.20M$ -582.12M$ -306.08M$ -453.38M
Operating Income
$ 218.08M$ -267.82M$ -536.20M$ -449.71M$ -564.16M
Other Income/Expenses
$ 42.69M$ -252.27M$ -153.76M$ 40.76M$ 11.10M
Pretax Income
$ 260.77M$ -520.10M$ -689.96M$ -418.95M$ -553.07M
Net Income
$ 235.24M$ -535.98M$ -703.49M$ -418.78M$ -554.13M
Per Share Metrics
Basic EPS
$ 2.47$ -5.80$ -8.03$ -5.15$ -7.11
Diluted EPS
$ 2.18$ -5.80$ -8.03$ -5.15$ -7.11
Weighted Average Shares Outstanding
95.08M 92.40M 87.56M 81.26M 77.96M
Weighted Average Shares Outstanding (Diluted)
107.88M 92.40M 87.56M 81.26M 77.96M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis